David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease and running out of treatment options, David used his research skills to identify an existing drug that saved his life. Join David and Medidata CEO Anthony Costello to explore the origins of Every Cure—and how David’s experience became the seed for a nonprofit that uncovers life-changing uses for treatments already approved for other conditions. Discover Every Cure’s innovative approaches to AI and data, the scope of unmet needs across healthcare, and how pharmaceutical companies can contribute to a future where we unlock the full potential of treatments for all. Episode Chapters: 00:00: Introduction 03:41: David’s story 10:26: The origin of Every Cure 13:08: Drug repurposing and knowledge graphs 17:19 Repurposing drugs using AI at scale 26:53: Every Cure’s projects: From breast cancer to Bachmann-Bupp 33:47: David’s call-to-action: The role for pharma companies in drug repurposing 42:01: Looking to the past and future of Every Cure Visit our website: https://mdso.io/63cddc Read our blog: https://mdso.io/ze1 Follow Medidata LinkedIn: https://mdso.io/s7r Instagram: https://mdso.io/rng X: https://mdso.io/8du Follow Anthony LinkedIn: https://mdso.io/mfp Follow David LinkedIn: https://mdso.io/fvms

 29      1